Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| GeneDx Holdings Corp.CL A(WGS) | 3,007,164 | 3,007,164 | 0 | $323.99M | $391.11M | 24.29% | +$67.12M |
| Revolution Medicines, Inc.(RVMD) | 2,647,333 | 2,577,333 | -70,000 | $123.63M | $205.28M | 12.75% | +$81.65M |
| Biolife Solutions Inc | 6,707,165 | 5,957,165 | -750,000 | $171.10M | $144.04M | 8.95% | -$27.06M |
| Standard BioTools Inc.(LAB) | 77,558,856 | 88,783,856 | +11,225,000 | $100.83M | $113.64M | 7.06% | +$12.82M |
| Relay Therapeutics, Inc.(RLAY) | 11,341,381 | 13,003,574 | +1,662,193 | $59.20M | $110.01M | 6.83% | +$50.81M |
| Structure Therapeutics IncADS | 1,555,000 | 1,175,000 | -380,000 | $43.54M | $81.72M | 5.08% | +$38.18M |
| Illumina, Inc.(ILMN) | 525,000 | 600,000 | +75,000 | $49.86M | $78.70M | 4.89% | +$28.84M |
| Avidity Biosciences Inc | 1,780,000 | 1,000,000 | -780,000 | $77.55M | $72.13M | 4.48% | -$5.42M |
| Beam Therapeutics Inc.(BEAM) | 1,600,000 | 1,600,000 | 0 | $38.83M | $44.35M | 2.75% | +$5.52M |
| Guardant Health, Inc.(GH) | 100,000 | 380,000 | +280,000 | $6.25M | $38.81M | 2.41% | +$32.57M |
| Maze Therapeutics, Inc.(MAZE) | 758,857 | 758,857 | 0 | $19.68M | $31.44M | 1.95% | +$11.76M |
| Denali Therapeutics Inc.(DNLI) | 890,000 | 1,840,000 | +950,000 | $12.92M | $30.38M | 1.89% | +$17.46M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 55,000 | 75,000 | +20,000 | $25.08M | $29.82M | 1.85% | +$4.74M |
| Neurogene Inc.(NGNE) | 1,295,361 | 1,295,361 | 0 | $22.45M | $26.68M | 1.66% | +$4.24M |
| 10x Genomics, Inc.CL A(TXG) | 0 | 1,400,000 | +1,400,000 | $0 | $22.83M | 1.42% | +$22.83M |
| ARS Pharmaceuticals, Inc.(SPRY) | 1,600,000 | 1,600,000 | 0 | $16.08M | $18.64M | 1.16% | +$2.56M |
| Tempus AI, Inc.CL A(TEM) | 294,127 | 294,127 | 0 | $23.74M | $17.37M | 1.08% | -$6.37M |
| UnitedHealth Group Incorporated(UNH) | 25,000 | 50,000 | +25,000 | $8.63M | $16.51M | 1.03% | +$7.87M |
| Septerna, Inc.(SEPN) | 553,268 | 553,268 | 0 | $10.41M | $15.43M | 0.96% | +$5.02M |
| Hims & Hers Health, Inc.CL A(HIMS) | 230,000 | 385,000 | +155,000 | $13.05M | $12.50M | 0.78% | -$544.6K |
| Veracyte, Inc.(VCYT) | 276,308 | 276,308 | 0 | $9.49M | $11.63M | 0.72% | +$2.15M |
| DexCom, Inc.(DXCM) | 0 | 175,000 | +175,000 | $0 | $11.61M | 0.72% | +$11.61M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 260,000 | +260,000 | $0 | $11.45M | 0.71% | +$11.45M |
| The Cigna Group(CI) | 0 | 40,000 | +40,000 | $0 | $11.01M | 0.68% | +$11.01M |
| Prime Medicine, Inc.(PRME) | 3,167,175 | 3,167,175 | 0 | $17.55M | $10.99M | 0.68% | -$6.56M |
| Incyte Corporation(INCY) | 100,000 | 100,000 | 0 | $8.48M | $9.88M | 0.61% | +$1.40M |
| Quest Diagnostics Incorporated(DGX) | 0 | 50,000 | +50,000 | $0 | $8.68M | 0.54% | +$8.68M |
| Taysha Gene Therapies, Inc.(TSHA) | 0 | 1,500,000 | +1,500,000 | $0 | $8.25M | 0.51% | +$8.25M |
| Pacific Biosciences of California, Inc.(PACB) | 723,767 | 4,223,767 | +3,500,000 | $926.4K | $7.90M | 0.49% | +$6.97M |
| Legend Biotech CorporationADS(LEGN) | 0 | 215,000 | +215,000 | $0 | $4.67M | 0.29% | +$4.67M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 282,312 | 282,312 | 0 | $3.27M | $3.53M | 0.22% | +$265.4K |
| Absci Corporation | 973,260 | 973,260 | 0 | $2.96M | $3.40M | 0.21% | +$438.0K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 148,333 | 148,333 | 0 | $1.74M | $1.70M | 0.11% | -$47.5K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 86,014 | 86,014 | 0 | $637.4K | $1.35M | 0.08% | +$711.3K |
| Century Therapeutics, Inc.(IPSC) | 1,228,190 | 1,228,190 | 0 | $611.6K | $1.22M | 0.08% | +$610.2K |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 165,323 | 165,323 | 0 | $806.8K | $676.2K | 0.04% | -$130.6K |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 36,493 | 36,493 | 0 | $532.1K | $303.3K | 0.02% | -$228.8K |
| Tenaya Therapeutics, Inc.(TNYA) | 361,969 | 361,969 | 0 | $586.4K | $257.5K | 0.02% | -$328.8K |
| Endeavour Silver Corp.(EXK) | 90,000 | 0 | -90,000 | $4.92M | $0 | — | -$4.92M |